Chioma M Oringanje1,2, Anthony Okoro3, Ogonna N Nwankwo2,4, Martin M Meremikwu2,5. 1. GIDP Entomology and Insect Science, University of Tucson, Tucson, AZ, USA. 2. Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria. 3. Cross River Health and Demographic Surveillance System, University of Calabar, Calabar, Nigeria. 4. London School of Hygiene and Tropical Medicine, London, UK. 5. Department of Pediatrics, College of Medical Sciences, University of Calabar, Calabar, Nigeria.
Abstract
BACKGROUND: The persistence of female genital mutilation (FGM) in some countries, despite an overall decline in the prevalence of the practice, calls for improvement in the capacity of healthcare workers and institutions to provide optimal care for this population. OBJECTIVES: To determine the impact of providing information on FGM and its consequences to healthcare providers on their attitudes toward FGM, and quality of care and patient satisfaction. SEARCH STRATEGY: The following major databases were searched from inception to August 2015: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, SCOPUS, Web of Science, and ClinicalTrials.gov, without language restrictions. SELECTION CRITERIA: Controlled studies were included based on use of objective measures. DATA COLLECTION AND ANALYSIS: Two team members independently screened and collected data. Relative risks and proportions were calculated and evidence assessed using the GRADE (Grade of Recommendation, Assessment, Development and Evaluation) approach. RESULTS: One study was identified. Based on this study there was no evidence to suggest change in healthcare provider outcomes after the intervention. CONCLUSIONS: Despite a comprehensive search, only one study of low methodological quality was included. This precludes a definitive conclusion regarding the impact of providing information on FGM to healthcare providers. More research is needed. PROSPERO REGISTRATION: CRD42015024570.
BACKGROUND: The persistence of female genital mutilation (FGM) in some countries, despite an overall decline in the prevalence of the practice, calls for improvement in the capacity of healthcare workers and institutions to provide optimal care for this population. OBJECTIVES: To determine the impact of providing information on FGM and its consequences to healthcare providers on their attitudes toward FGM, and quality of care and patient satisfaction. SEARCH STRATEGY: The following major databases were searched from inception to August 2015: Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, SCOPUS, Web of Science, and ClinicalTrials.gov, without language restrictions. SELECTION CRITERIA: Controlled studies were included based on use of objective measures. DATA COLLECTION AND ANALYSIS: Two team members independently screened and collected data. Relative risks and proportions were calculated and evidence assessed using the GRADE (Grade of Recommendation, Assessment, Development and Evaluation) approach. RESULTS: One study was identified. Based on this study there was no evidence to suggest change in healthcare provider outcomes after the intervention. CONCLUSIONS: Despite a comprehensive search, only one study of low methodological quality was included. This precludes a definitive conclusion regarding the impact of providing information on FGM to healthcare providers. More research is needed. PROSPERO REGISTRATION: CRD42015024570.